Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol

Journal of Pharmaceutical Analysis

Volumn 2, Issue 2, 2012, Pages 136-142

  Rane, Shaligram S ^a,b   Ajameri, Alkesh ^b   Mody, Rustom ^b   Padmaja, P ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b Intas Biopharmaceuticals Ltd   (India)

Author keywords

Meta cresol; Parathyroid hormone; Reversed phase high performance liquid chromatography; Ultra performance liquid chromatography; Validation

Indexed keywords

ACETONITRILE; META CRESOL; PARATHYROID HORMONE[1-34];

ACCURACY; ARTICLE; DRUG FORMULATION; DRUG QUALITY; DRUG STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION STUDY;

EID: 84925835396     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpha.2011.12.001     Document Type: Article

References (21)

1. L. Jin, S.L. Briggs, and S. Chandrasekhar Crystal structure of human parathyroid hormone 1-34 at 0.9-A resolution J. Biol. Chem. 275 35 2000 27238 27244
2. G.N. Hendy, H.M. Kronengerg, and J.T. Potts Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone Proc. Natl. Acad. Sci. USA 78 12 1981 7365 7369 (Pubitemid 12186141)
3. J.T. Potts Jr., H.M. Kronengerg, and M. Rosenblatt Parathyroid hormone: chemistry, biosynthesis, and mode of action Adv. Protein Chem. 35 1982 323 396
4. R.M. Neer, C.D. Arnaud, and J.R. Zanchetta Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N. Engl. J. Med. 344 2001 1434 1441 (Pubitemid 32402100)
5. J. Reeve, J.N. Bradbeer, and M. Arlot hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses Osteoporos. Int. 1 1991 162 170
6. A.B. Hodsman, L.J. Fraher, and T. Ostbye An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis J. Clin. Invest. 91 1993 1138 1148 (Pubitemid 23095292)
7. A.B. Hodsman, L.J. Fraher, and P.H. Watson A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis J. Clin. Endocrinol. Metab. 82 1997 620 628 (Pubitemid 27068640)
8. R. Lindsay, J. Nieves, and C. Formica Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 350 1997 550 555 (Pubitemid 27348431)
9. N.E. Lane, S. Sanchez, and G.W. Modin Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial J. Clin. Invest. 102 1998 1627 1633 (Pubitemid 28492231)
10. N.E. Lane, S. Sanchez, and H.K. Genant Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis Osteoporos. Int. 11 2000 434 442 (Pubitemid 30450127)
11. E.K. Armitage Parathyrin (parathyroid hormone): metabolism and methods for assay Clin. Chem. 32 1986 418 424 (Pubitemid 17016953)
12. D.B. Endres, R. Villanueva, and F.R. Singer Measurement of parathyroid hormone Endocrinol. Metab. Clin. North Am. 18 1989 611 629 (Pubitemid 19233006)
13. G.V. Segre, and J.T. Potts Jr. Differential Diagnosis of Hypercalcemia. Methods and Clinical Applications of Parathyroid Assays, Endocrinology vol. 2 1989 W.B. Saunders company PA pp. 9841001
14. Y. Nabuchi, E. Fujiwara, and H. Kuboniwa Kinetic study of methionine oxidation in human parathyroid hormone Anal. Chim. Acta 365 1998 301 307 (Pubitemid 28254765)
15. C. Burns, M. Moore, C. Sturgeon, et al., WHO International Collaborative Study of the proposed 1st International Standard for Parathyroid Hormone 1-84, Human, Recombinant, 2009, WHO/BS/09.2115.
16. R. Bhushan, and R. Agarwal Liquid chromatographic separation of some PTH-amino acids Biomed. Chromatogr. 12 1998 322 325 (Pubitemid 28542597)
17. A.L. Frelinger, and J.E. Zulls Oxidized forms of parathyroid hormone with biological activity - Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18 J. Biol. Chem. 259 1984 5507 5513
18. Y. Nabuchi, E. Fujiwara, and K. Ueno Oxidation of recombinant human parathyroid hormone: Effect of oxidized position on biological activity Pharm. Res. 12 1995 2049 2052 (Pubitemid 26031794)
19. Reviewer guidance Validation of chromatographic methods, Center for drug evaluation and research (CDER), November 1994.
20. United States Pharmacopeia, 29th ed., United States Pharmacopeial Convention, Inc, Twinbrook Parkway, Rockville, MD, USA, 2006, pp. 1623, 26752693, 30503053, 33923394.
21. ICH harmonized tripartite guideline, Validation of Analytical Procedures: Text and Methodology, Q2-R1, 2005.